BioCardia (NSDQ:BCDA) has registered for an upcoming offering of its common stock, looking to raise approximately $18 millions according to an SEC filing.
The company has not yet set a price range for the offering, nor has it stated how many shares it is looking to float.
San Carlos, Calif.-based BioCardia did note the closing price of its stock on April 8 as being $1.33 per share.
The offering will include warrants to purchase additional common stock, according to the filing.
Last December, BioCardia said that it submitted an application for FDA 510(k) clearance for its Avance steerable introducer intended for introducing cardiovascular catheters into the heart, including the left side of the heart through the interatrial septum.
from MassDevice http://bit.ly/2G3WqQp
Cap comentari:
Publica un comentari a l'entrada